Fingerprint
Dive into the research topics of 'Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically